Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -5.74% vs -22.68% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -50.51% vs -24.25% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -56.34% vs -17.09% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 118.18% vs -29.79% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Zhejiang Shouxiangu Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 23.37% vs 1.24% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -5.74% vs -22.68% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 167.59% vs 50.00% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -50.51% vs -24.25% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 393.10% vs -74.45% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -56.34% vs -17.09% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -1.37% vs 15.87% in Sep 2025
YoY Growth in quarter ended Mar 2026 is 118.18% vs -29.79% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






